Language selection

Search

Details for: XALKORI

Company: PFIZER CANADA ULC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02384256XALKORICRIZOTINIB200 MGCAPSULEORAL
02384264XALKORICRIZOTINIB250 MGCAPSULEORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Regulatory Decision Summary
Summary Safety Review - XALKORI (crizotinib) - Assessing the potential risk of developing a hole in the bowel (gastrointestinal perforation)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: